Skip to content

Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App

An Observational Cross-Sectional Study of Early Detection of 5 Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06301087
Enrollment
55618
Registered
2024-03-08
Start date
2022-05-01
Completion date
2024-02-08
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development, Child, Postnatal Depression

Keywords

early detection, neurodevelopmental disorders, postnatal depression, mHealth, real-world study, smartphone

Brief summary

The goal of this observational study is to confirm the impact of using this app adapted to be more specific for screening for 5 neurodevelopmental disorders and to evaluate the mothers' support program on the incidence of postpartum depression in of young parents with a minimum of 1 child under 10 years of age at the time of inclusion and using Malo on a regular basis. The main questions it aims to answer are : * the median age of possible neurodevelopmental disorders notification of infants * the median time of the mothers' postnatal depression notifications after childbirth subsequently to the support and prevention program Participants will agree with use of their data

Interventions

web application for monitoring children's development and postnatal depression of mothers

Sponsors

Kelindi
CollaboratorINDUSTRY
Weprom
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Youg parent with a minimum of 1 child under 10 years * User of the app (downloaded) * Having given informed consent (in-app)

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Time to neurodevelopment desorder diagnostic20 monthsNumber of days between birth and notification of possible neurodevelopment desorder notification

Secondary

MeasureTime frameDescription
User's satisfaction20 monthsHome made qualitatif satisfaction questionnaire
Relevance of the neurodevelopmental desorder notification20 monthsParent's feedback for physician's opinion after notification
Rate of mothers'postnal depression20 monthsNumber of mothers with grade 2 ou 3 at adapted Edimbourg postnatal depression scale
Time of mothers'postnatal depression7 monthsNumber of days between Edimbourg postnatal depression scale grade 2 or 3 and childbirth (score 0 to 30 a higher score indicates a worse condition)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026